Key result
Phenotype-positive pediatric Brugada syndrome is linked to 100% of observed arrhythmic hospitalizations.
Why the study?
Brugada syndrome typically presents in young adults and can be diagnosed in children, but data in paediatric patients remain scarce.
Cohort (n=30)
No
In children with Brugada syndrome, rhythm and conduction disturbances occur primarily in those with a positive phenotype, whereas phenotype-negative patients appear to have a benign clinical course.
Supports phenotype-based risk stratification in pediatric Brugada syndrome; leaves open need for prospective validation before changing surveillance.
AIMS: Brugada syndrome is an inherited condition, which typically presents in young adults. It can also be diagnosed in children, but data in this group remain scarce. This study aims to describe the clinical features, management, and follow-up of children with personal or family history of Brugada syndrome. METHODS: Retrospective study of consecutive patients with Brugada history followed up in a tertiary paediatric referral centre between 2009 and 2021. Patients were assessed according to the phenotype: positive (with variable genotype) or negative (with positive genotype). RESULTS: Thirty patients were included (mean age at diagnosis 7 ± 6 years, 53% male). Within the positive phenotype (n = 16), 81% were male, and 88% had spontaneous type 1 ECG pattern. A genetic test was performed in 88% and was positive in 57%. Fourteen patients had a negative phenotype-positive genotype, 79% female, all diagnosed during family screening; 43% mentioned family history of sudden cardiac death. Although most of the patients were asymptomatic, the prevalence of rhythm/conduction disturbances was not negligible, particularly if a positive phenotype. No clinically significant events were reported in the negative phenotype patients. Three patients were hospitalised due to an arrhythmic cause, all in patients with a positive phenotype. CONCLUSION: In our study, the documentation of rhythm and conduction disturbances was not infrequent, especially in patients with a positive phenotype. Despite the significant family history, phenotype negative patients had no relevant events during follow-up. Nevertheless, the management of these patients is not clear cut, and a personalised therapeutic strategy with close follow-up is essential.
No takes yet. Share an insight, caveat, or question.
Fernandes et al. (2022) conducted a cohort in Brugada syndrome (n=30).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: